Crum, CP. (1999). The Female Genital Tract. In RS Cotran, V Kumar, & T Collins (Eds.), Pathologic Basis of Disease. Philadelphia, PA: WB Saunders, Co.

Cramer, SF, & Patel, A.(1990). The frequency of uterine leiomyomas. American Journal of Clinical Pathology. 94, 435-438.

Easterday, CL, Grimes, DA, & Riggs, JA. (1983). Hysterectomy in the United States. Obstet Gynecol, 62, 203-212.

Pritts, EA. (2001). Fibroids and infertility: A systematic review of the evidence. Obstet Gynecol Surv, Aug;58(8), 483-491.

Newbold, RR, DiAugustine, RP, Risinger, JI, Everitt, JI, Walmer, DK, Parrott, EC, & Dixon, D. (2000). Advances in uterine leiomyoma research: Conference overview, summary, and future research recommendations. Environ Health Perspect, 108(suppl 5), 769-773.

Levy B, Mukherjee T, & Hirschhorn K. (2000). Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization. Cancer Genet Cytogenet, Aug;121(1), 1-8.

Schwartz, S, Marshall, L, & Baird, D. (2000). Epidemiologic contributions to understanding the etiology of uterine leiomyomata. Environ Health Perspect, 108(Suppl 5), 821-827.

Treloar, SA, Martin, NG, Dennerstein, L, Raphael, B, & Heath, AC. (1992). Pathways to hysterectomy: Insights from longitudinal twin research. Am J Obstet Gynecol,167(1), 82-88.

Women's Health and the Environment: The Next Century—Advances in Uterine Leiomyoma Research, Conference Proceedings, October 7-8, 1999. (2000). Environ Health Perspect, 108(suppl 5), 767-853.

Management of Uterine Fibroids. (2001) Summary, Evidence Report/Technology Assessment: Number 34. AHRQ Publication No. 01-E051. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/epcsums/utersumm.htm

National Institute of Child Health and Human Development

NIH Pub. No. 02-7103 June 2002

  previous